Common use of INVESTIGATIONAL PRODUCT Clause in Contracts

INVESTIGATIONAL PRODUCT. 8.1 The Institution must: (1) ensure that all Investigational Product made available by the Sponsor is used strictly according to the Protocol and are not used for any other purposes, unless agreed in writing by the Sponsor; (2) provide a written explanation accounting for any missing Investigational Product; (3) not charge a Study Subject or third party payer for Investigational Product or for any services reimbursed by the Sponsor under this Agreement; and (4) keep all Investigational Product under appropriate storage conditions as specified in the Protocol in a secured area accessible only to authorised Personnel, and that complete and current records are maintained for all received, dispensed and returned Investigational Product. 8.2 The Sponsor will supply the Principal Investigator with such quantities of the Investigational Product as will be required for the purpose of the Study. All supplied Investigational Product will be packaged in safe and appropriately labelled containers. The Sponsor will at all times remain the sole owner of the Investigational Product. 8.3 In the event of termination, the Institution must promptly return (or destroy if requested by the Sponsor, and provide evidence of such destruction) to the Sponsor any unused Investigational Product.

Appears in 2 contracts

Samples: Clinical Trial Research Agreement, Clinical Trial Research Agreement

AutoNDA by SimpleDocs

INVESTIGATIONAL PRODUCT. 8.1 The Institution must: (1) ensure that all Investigational Product made available by the Sponsor is used strictly according to the Protocol and are not used for any other purposes, unless agreed in writing by the Sponsor; (2) provide a written explanation accounting for any missing Investigational Product; (3) not charge a Study Subject Participant or third party payer for Investigational Product or for any services reimbursed by the Sponsor under this Agreement; and; (4) keep all Investigational Product under appropriate storage conditions as (including any conditions specified in the Protocol Protocol) and in a secured area accessible only to authorised Personnel, and ; and (5) ensure that complete and current records are maintained for all received, dispensed and returned Investigational Product. 8.2 The Sponsor will supply the Principal Investigator with such quantities of the Investigational Product as will be required for the purpose of the Study. All supplied Investigational Product will be packaged in safe and appropriately labelled containers. The Sponsor will at all times remain the sole owner of the Investigational Product. 8.3 In the event On termination of terminationthis Agreement, the Institution must promptly return (or destroy any unused Investigational Product to the Sponsor, or, if requested by the Sponsor, destroy it and provide evidence of such destruction) to the Sponsor any unused Investigational Product.

Appears in 1 contract

Samples: Clinical Trial Research Agreement

INVESTIGATIONAL PRODUCT. 8.1 The Institution must: (1) ensure that all Investigational Product made available by the Sponsor is used strictly according to the Protocol and are not used for any other purposes, unless agreed in writing by the Sponsor; (2) provide a written explanation accounting for any missing Investigational Product; (3) not charge a Study Subject Participant or third party payer for Investigational Product or for any services reimbursed by the Sponsor under this Agreement; and; (4) keep all Investigational Product under appropriate storage conditions as (including any conditions specified in the Protocol Protocol) and in a secured area accessible only to authorised Personnel, and ; and (5) ensure that complete and current records are maintained for all received, dispensed and returned Investigational Product. 8.2 The Sponsor will supply the Principal Investigator with such quantities of the Investigational Product as will be required for the purpose of the Study. All supplied Investigational Product will be packaged in safe and appropriately labelled containers. The Sponsor will at all times remain the sole owner of the Investigational Product.Product.‌ 8.3 In the event On termination of terminationthis Agreement, the Institution must promptly return (or destroy any unused Investigational Product to the Sponsor, or, if requested by the Sponsor, destroy it and provide evidence of such destruction) to the Sponsor any unused Investigational Product.destruction.‌

Appears in 1 contract

Samples: Clinical Trial Research Agreement

INVESTIGATIONAL PRODUCT. 8.1 The Institution must: (1) ensure that all Investigational Product made available by the Sponsor is used strictly according to the Protocol Clinical Investigation Plan and are is not used for any other purposes, unless agreed in writing by the Sponsor; (2) provide a written explanation accounting for any missing Investigational Product;Product;‌ (3) not charge a Study Subject or third party payer for Investigational Product or for any services reimbursed by the Sponsor under this Agreement; and (4) keep all Investigational Product under appropriate storage conditions as specified in the Protocol Clinical Investigation Plan in a secured an appropriately secure area accessible only to authorised Personnel, and that complete and current records are maintained for all received, dispensed used and returned Investigational Product. 8.2 The Sponsor will supply the Principal Investigator with such quantities of the Investigational Product as will be required for the purpose of the Study. All supplied Investigational Product will be packaged in safe and appropriately labelled containers. The Sponsor will at all times remain the sole owner of the Investigational Product. 8.3 In the event of termination, the Institution must promptly return (or destroy if requested by the Sponsor, and provide evidence of such destruction) to the Sponsor any unused Investigational Product.Product.‌‌

Appears in 1 contract

Samples: Clinical Investigation Research Agreement

AutoNDA by SimpleDocs

INVESTIGATIONAL PRODUCT. 8.1 The Institution must: (1) ensure that all Investigational Product made available by the Sponsor is used strictly according to the Protocol Clinical Investigation Plan and are is not used for any other purposes, unless agreed in writing by the Sponsor; (2) provide a written explanation accounting for any missing Investigational Product; (3) not charge a Study Subject or third party payer for Investigational Product or for any services reimbursed by the Sponsor under this Agreement; and (4) keep all Investigational Product under appropriate storage conditions as specified in the Protocol Clinical Investigation Plan in a secured an appropriately secure area accessible only to authorised Personnel, and that complete and current records are maintained for all received, dispensed used and returned Investigational Product. 8.2 The Sponsor will supply the Principal Investigator with such quantities of the Investigational Product as will be required for the purpose of the Study. All supplied Investigational Product will be packaged in safe and appropriately labelled containers. The Sponsor will at all times remain the sole owner of the Investigational Product. 8.3 In the event of termination, the Institution must promptly return (or destroy if requested by the Sponsor, and provide evidence of such destruction) to the Sponsor any unused Investigational Product.

Appears in 1 contract

Samples: Clinical Investigation Research Agreement

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!